Description: 2cureX AB (publ) operates as a medtech company in Europe. The company's principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. It is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers. The company was incorporated in 2006 and is based in Copenhagen, Denmark.
Home Page: www.2curex.com
Fruebjergvej 3
Copenhagen,
2100
Denmark
Phone:
45 22 11 53 99
Officers
| Name | Title |
|---|---|
| Mr. Ole Thastrup VD | Co-Founder, CEO & Vice Chairman |
| Ms. Grith Hagel | Co-Founder, VP of Innovation & Director |
| Mr. Kenneth Graabek Johansen | Chief Financial Officer |
| Mr. Jacob Thastrup | Chief Technology Officer |
| Mr. Manuel Fernandez | Director Quality & Regulatory Affairs |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.3245 |
| Price-to-Sales TTM: | 0.3023 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 14 |